Corporate News

Bad Neustadt a. d. Saale | 27 March 2025

RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned

RHÖN-KLINIKUM AG has met its financial targets as per forecast. Revenue increased by 131.6 million euros to reach 1,595.6 million euros (previous year: 1,464.0 million euros). The increase was driven by growth in patient numbers and related services. A total of 912,965 patients (previous year: 881,775) were treated on an inpatient and outpatient basis in the Group’s hospitals and medical care centres – an increase of 3.5 per cent. Consolidated profit improved by 5.0 million euros to 45.2 million euros (previous year: 40.2 million euros).  Earnings before interest, taxes, depreciation and amortisation (EBITDA) recorded at 110.8 million euros (previous year: 105.9 million euros). Materials and consumables used increased as a result of higher purchasing prices to 535.5 million euros (previous year: 488.5 million euros).

“RHÖN-KLINIKUM AG can once again look back on a successful financial year in 2024 with a satisfactory performance. Our forecasted performance indicators were reached, with revenues and earnings going up for the third year in a row. This is more than remarkable given the trend in the sector, which for three years has been going in exactly the opposite direction”, said Dr. Stefan Stranz, member of the Board of Management of RHÖN-KLINIKUM AG.

The Company has been very quick to adapt to the tremendous challenges faced by the sector whilst also anticipating how to leverage its portfolio, structures and processes to prepare for the new requirements introduced by the reform. This in turn enables stable earnings to be generated.

Acting sustainably is a non-negotiable for RHÖN-KLINIKUM AG. To achieve this goal, the Company has set sustainability targets. In the environmental area, RHÖN is striving to significantly reduce the CO₂ emissions of its healthcare facilities (Scope 1 and 2). We are also aiming to lower waste volumes in proportion to patient numbers. Currently, a transition plan for climate change mitigation is being prepared and, in this context, the sustainability strategy adapted. The strategy is to complete and implement the plan  within the next three years. We report on this in our Sustainability Report, in which we adopted ESRS Standards following the European CSRD Directive for the first time.

Change on the Board of Management

Given the Group’s ongoing integration into the Asklepios Group, the Supervisory Board of RHÖN-KLINIKUM AG, in close consultation with Prof. Dr. Tobias Kaltenbach, chairman of the Board of Management of RHÖN-KLINIKUM AG, has taken a further strategic move by reducing the size of the Board of Management of the Company to two individuals. In this context, Prof. Dr. Kaltenbach (64) will leave the Board of Management with effect from 31 March 2025. As of 1 April 2025 the Board of Management of the Company will thus consist of Dr. Stefan Stranz and Dr. Gunther K. Weiß. Prof. Dr. Kaltenbach had been serving as chairman of the Board of Management since 2023.

“On behalf of the Supervisory Board, I wish to express my sincere thanks to Prof. Dr. Tobias Kaltenbach for his tremendous service. He has not only ushered in important steps in the strategic partnership of RHÖN and Asklepios, but was also decisive in brokering the White Paper Plus agreement on further cooperation with the Federal State of Hesse at Universitätsklinikum Gießen und Marburg (UKGM). It was also under his leadership that RHÖN-KLINIKUM AG succeeded in continuously improving its financial results. Together with the entire Supervisory Board, I wish Prof. Dr. Tobias Kaltenbach every success both personally and in his future career,” said Dr. Jan Liersch, chairman of the Supervisory Board of RHÖN-KLINIKUM AG.

Prof. Dr. Kaltenbach added: “The past years have been intense, bringing tremendous challenges which we have overcome as we worked together with the Supervisory Board on the basis of mutual trust. That is something I am very grateful for. I also wish to extend my special thanks to our more than 18,000 employees for the decisive contributions they have made to the Company’s overall success thanks to their hard work, loyalty and commitment. Each and every one of them plays a key role in this outstanding team.”

Outlook for 2025

For the coming financial year, we expect revenue of € 1.7 billion within a range of plus or minus 5%. For earnings before interest, tax and depreciation/amortisation (EBITDA), we expect a level of between € 110 million and € 125 million. In addition to the financial numbers, we also take account of the non-financial performance indicators of number of cases and cost weights in the management of the Company and expect these to show a moderate increase over the previous year.

This forecast reflects the heightened regulatory interference by the German legislator and the political implementation of the necessary hospital reform.

We note that our outlook is subject to considerable uncertainties in connection with the numerous global crises resulting among other things in higher prices and supply chain issues, as well as any further regulatory measures impacting our remuneration structure for medical services in 2025.

RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. The hospitals offer excellent medical care with a direct tie-in to universities and research facilities. Each year some 912,965 patients are treated at our five sites of Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen and Universitätsklinikum Marburg (UKGM) as well as Zentralklinik Bad Berka. The Company employs over 18,700 persons. The innovative RHÖN Campus approach for cross-sector and future-oriented healthcare delivery in rural areas, the steadfast continuation of the gradual digital transformation within the Company as well as the strategic partnership with Asklepios are important elements of our corporate strategy. RHÖN-KLINIKUM AG is an independent Company operating under the umbrella of Asklepios Kliniken GmbH & Co. KGaA. www.rhoen-klinikum-ag.com

Annual Report 2024 

Contact: RHÖN-KLINIKUM AG |Head of Corporate Finance, Treasury, Investor Relations and SustainabilityJulian Schmitt T. +49 9771 65-12250 | julian.schmitt(at)rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale